CT, PET-CT, MRI 판독결과 해석 좀 부탁드립니다.

[big eye]

제 아내가 얼비툭스를 16차까지 썼는데 내성이생겼는지 오늘부터 아바스틴으로 바꾸기로 했습니다.

이제 마지막남은 표적치료제인데 제발 잘 맞기를 기원하며,

아래의 판독결과가 궁금하여 문의드립니다. 아시는분은 꼭! 해석 좀 해주세요~ 부탁드립니다!!!

ct chest&hr double study(contrast)

comparing to previous chest ct taken on 2009-11-3,

no remarkable interval change of the multiple nodules in the bilateral lung.

no remarkable interval change of the residual lns in the lt supraclavicular fossa.

no evidence of newly developed lesion in the thorax.

imp>no interval change of hematogeneous lung metastasis.

=========================================================================================================

ct abd+pel dynamic(contrast)

compared to previous ct dated 2009-11-03.

no change of primary lesion at upper rectum and sigmoid colon.

no remarkable change of multiple ln metastasis in the regional area and both pelvic sidewall,

bilateral common iliac axis, aortocaval, paraaortic space and retrocrural space.

decreased size of previously seen cystic lesion in right ovary, functional cyst rather than metastasis.

heterogenous attenuation and enhancement of uterus, r/o adenomyosis. rec) gyn sono correlation.

no remarkable interval change of size and number of multiple metastasis in both lung.

imp: stable disease.

===================================================================================================================

pet-ct whole body scan(torso+additional)

F-18 FDG was given to the patient intravenously. 

pet imaging using a standard protocol was performed from the neck to the proximal thighs.

additional pet imaging of the abdomen and pelvis was obtained.

the obtained images were reconstructed into axial, sagittal, and coronal planes.

ct scan was performed from the neck to the proximal thighs after pet scan with contrast

(omnipaque 300 inj, 150ml, 1 vial)administration.

1. diffuse mural thickening with markedly increased fdg uptake from mid rectum to distal signmoid,

consistent with clinically informed colon cancer.

2. pericolic fat infiltration and numerous regional ln enlargement are noted.

3. extensive metastatic lymphadennopathy along the bilateral pelvic walls, bilateral common iliacaxis,

abdominal aorta, and in the left axilla, left supraclavicular ln bearing areas.

4. multiple hematogeneous lung metastases.

==============================================================================================================================

mri rectal(contrast)*pre-op*

1. advanced lesion 11cm above anal verge to the distal sigmoid level with definite extramural fat extention.

2. multiple ln metastasis in the regional area and both pelvic side wall and bilateral common iliac axis.